Gene · 2182
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Receptor accessory protein 6, a novel ferroptosis suppressor, drives oral squamous cell carcinoma by maintaining endoplasmic reticulum hemostasis. | Int J Biol Macromol | 2024 | 39566754 | PubTator, text mining | PubMed |
| Role of Hippo/ACSL4 axis in ferroptosis-induced pericyte loss and vascular dysfunction in sepsis. | Redox Biol | 2024 | 39566164 | PubTator, text mining | PubMed |
| The prognostic role of ACSL4 in postoperative adjuvant TACE-treated HCC: implications for therapeutic response and mechanistic insights. | J Exp Clin Cancer Res | 2024 | 39563427 | PubTator, text mining | PubMed |
| GPX4 Promoter Hypermethylation Induced by Ischemia/Reperfusion Injury Regulates Hepatocytic Ferroptosis. | J Clin Transl Hepatol | 2024 | 39544244 | PubTator, text mining | PubMed |
| Repurposed genipin targeting UCP2 exhibits antitumor activity through inducing ferroptosis in glioblastoma. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 39523775 | PubTator, text mining | PubMed |
| Evaluation of MYC Oncogene Expression in Human Breast Cancer and Its Relationship with ACSL4 and Lipin-1 Expression. | Adv Biomed Res | 2024 | 39512404 | PubTator, text mining | PubMed |
| Ferroptosis, oxidative stress and hearing loss: Mechanistic insights and therapeutic opportunities. | Heliyon | 2024 | 39512327 | PubTator, text mining | PubMed |
| FGF6 inhibits oral squamous cell carcinoma progression by regulating PI3K/AKT and MAPK pathways. | Sci Rep | 2024 | 39506091 | PubTator, text mining | PubMed |
| Pathological Characteristics of Ferroptosis in Kidney Tissues in Type 2 Diabetic Patients with Diabetic Kidney Disease. | Diabetes Metab Syndr Obes | 2024 | 39502451 | PubTator, text mining | PubMed |
| Development of oxidative stress- and ferroptosis-related prognostic signature in gastric cancer and identification of CDH19 as a novel biomarker. | Hum Genomics | 2024 | 39501397 | PubTator, text mining | PubMed |
| Inhibition of GPX4 enhances CDK4/6 inhibitor and endocrine therapy activity in breast cancer. | Nat Commun | 2024 | 39500869 | PubTator, text mining | PubMed |
| Synthesis, characterization and MAFLD prevention potential of Ganoderma lucidum spore polysaccharide-stabilized selenium nanoparticles. | Int J Biol Macromol | 2024 | 39490485 | PubTator, text mining | PubMed |
| GABPA inhibits tumorigenesis in clear cell renal cell carcinoma by regulating ferroptosis through ACSL4. | Sci Rep | 2024 | 39489850 | PubTator, text mining | PubMed |
| Emerging insights into ferroptosis in cholangiocarcinoma (Review). | Oncol Lett | 2024 | 39483963 | PubTator, text mining | PubMed |
| AMPD3 promotes doxorubicin-induced cardiomyopathy through HSP90α-mediated ferroptosis. | iScience | 2024 | 39474068 | PubTator, text mining | PubMed |
| Ion channel Piezo1 induces ferroptosis of trabecular meshwork cells: a novel observation in the pathogenesis in primary open angle glaucoma. | Am J Physiol Cell Physiol | 2024 | 39466179 | PubTator, text mining | PubMed |
| Serum ACSL4 levels in prostate cancer patients and its relationship between patient prognosis: A prospective observational study. | Medicine (Baltimore) | 2024 | 39465761 | PubTator, text mining | PubMed |
| Identification of lipid senolytics targeting senescent cells through ferroptosis induction. | bioRxiv | 2024 | 39463954 | PubTator, text mining | PubMed |
| Copper as the driver of the lncRNA-TCONS-6251/miR-novel-100/TC2N axis: Unraveling ferroptosis in duck kidney. | Int J Biol Macromol | 2024 | 39454920 | PubTator, text mining | PubMed |
| Reduced glutathione attenuates pediatric sepsis-associated encephalopathy by inhibiting inflammatory cytokine release and mitigating lipid peroxidation-induced brain injury. | Neuroreport | 2024 | 39445523 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2182/papers?page=51